Kai Markus Schneider

BACKGROUND: Existing literature provides compelling evidence that mutations in the glucagon-like peptide 1 receptor gene (GLP1R) are instrumental in the onset of obesity and type 2 diabetes (T2D). A cardinal dysfunction shared by both obesity and T2D is insulin resistance…